Advertisement

Biotechnology

  • Nayef R. F. Al-Rodhan
Part of the St Antony’s Series book series

Abstract

From stem cell research and genetically modified crops to anthrax and the manipulation of disease-causing agents, the science of biotechnology is truly at the centre of politics, religion, ethics and innovation. Biotechnology has enormous potential to improve life expectancy, food production and the treatment of illness and disease. It also has possible applications for the environment, manufacturing industries and in the creation of alternative energies, making it of huge interest to both the public and private sectors.1

Keywords

Synthetic Biology Nuclear Weapon Stem Cell Research Somatic Cell Nuclear Transfer Biotechnology Industry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. 2.
    D. Steele (2004), ‘Danger Lurks in a Biotech World’, The Aquarian, Spring, http://www.aquarianonline.com/Sci-Tech/Steele_Biotech.html, date accessed 11 August 2010.
  2. 4.
    Biotechnology Industry Organization (BIO) (2008), Guide to Biotechnology 2008 (Washington, D.C.: BIO), http://bio.org/speeches/pubs/er/BiotechGuide2008.pdf, date accessed 17 August 2010, p. 1.Google Scholar
  3. 5.
    European Commission (2002), Life Sciences and Biotechnology—A Strategy for Europe (Luxembourg: Office for Official Publications of the European Communities), http://ec.europa.eu/biotechnology/pdf/com2002-27_en.pdf, date accessed 11 August 2010, p. 10.Google Scholar
  4. 11.
    BIO (2008), Guide to Biotechnology 2008, p. 69.Google Scholar
  5. 13.
    T. Taylor (2010), ‘Biotechnology Industry’, Presentation at the Strategic Technologies and Our Global Future Course, Geneva Centre for Security Policy, Geneva, Switzerland, 15 April.Google Scholar
  6. 15.
    BIO (2008), Guide to Biotechnology 2008, p. 2.Google Scholar
  7. 17.
    BIO (2008), Guide to Biotechnology 2008, p. 2.Google Scholar
  8. 18.
  9. 19.
    National Research Council Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats (2006), Globalization, Biosecurity, and the Future of the Life Sciences (Washington, D.C.: The National Academies Press), p. 86.Google Scholar
  10. 20.
    S. Singh (2008), ‘Biotech Growth Slows for the First Time in 5 Years’, LiveMint.com, The Wall Street Journal, 15 July, http://www.livemint.com/2008/07/15215237/Biotech-growth-slows-for-first.html, date accessed 11 August 2010.
  11. 21.
  12. 24.
    A. Pollack and D. Wilson (2010), ‘Safety Rules Can’t Keep Up with Biotech Industry’, The New York Times, 27 May, http://www.nytimes.com/2010/05/28/business/28hazard.html?ref=biotechnology, date accessed 25 July 2010.
  13. 25.
    BIO (2007), Milestones 2006–2007 (Washington, D.C.: BIO), http://www.bio.org/speeches/pubs/milestone07/Milestones2007.pdf, date accessed 26 August 2010, p. 23.Google Scholar
  14. 28.
    BIO (2008), Guide to Biotechnology 2008, p. 18.Google Scholar
  15. 29.
  16. 31.
    BIO (2008), Guide to Biotechnology 2008, p. 18.Google Scholar
  17. 32.
    Ibid., p. 19.Google Scholar
  18. 33.
  19. 34.
    Ibid., p. 20.Google Scholar
  20. 35.
  21. 36.
    Ibid., p. 21.Google Scholar
  22. 37.
  23. 38.
    Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (2007), Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (Washington, D.C.: National Academies Press), p. 1.Google Scholar
  24. 40.
    Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment (2007), Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment, p. 1.Google Scholar
  25. 42.
    BIO (2008), Guide to Biotechnology 2008, p. 22.Google Scholar
  26. 45.
    K. Leutwyler (2001), ‘New Micromachined Cantilever Quickly Detects Disease Markers’, Scientific American, 4 September, http://www.scientificamerican.com/article.cfm?id=new-micromachined-cantile, date accessed 11 August 2010.
  27. 46.
  28. 47.
    International Society for Stem Cell Research (ICCSR) (2008), Stem-cell Facts: The Next Frontier? (Deerfield, IL: ICCSR), http://www.isscr.org/public/ISSCR08_PubEdBroch.pdf, date accessed 11 August 2010, p. 2.Google Scholar
  29. 48.
  30. 49.
  31. 50.
    Ibid., p. 3.Google Scholar
  32. 58.
    European Commission (2005), Synthetic Biology: Applying Engineering to Biology, Report of a NEST High-Level Expert Group (Brussels: European Commission), p. 5.Google Scholar
  33. 59.
    N. Wade (2010), ‘Researchers Say They Created a ‘Synthetic Cell’, The New York Times, 20 May, http://www.nytimes.com/2010/05/21/science/21cell.html, date accessed 11 August 2010.
  34. 60.
    S. Benner (2010), ‘Q&A: Life, Synthetic Biology and Risk’, BMC Biology, Vol. 8, 78.CrossRefGoogle Scholar
  35. 62.
    A.H. Cordesman (2005), The Challenge of Biological Terrorism (Washington, D.C.: CSIS Press), p. 91.Google Scholar
  36. 64.
    Cordesman (2005), The Challenge of Biological Terrorism, pp. 12–17.Google Scholar
  37. 67.
    Cf. J. Parachini (2002), ‘Control Biological Weapons, but Defend Biotechnology’, RAND Review, Vol. 26, No. 2, 34–35.Google Scholar
  38. 69.
    Cordesman (2005), The Challenge of Biological Terrorism, p. 93.Google Scholar
  39. 70.
    Ibid., p. 185.Google Scholar
  40. 72.
    Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology (2004), Biotechnology Research in an Age of Terrorism (Washington, DC: National Academies Press), p. 43.Google Scholar
  41. 73.
    Ibid., p. 44.Google Scholar
  42. 75.
    Cordesman (2005), The Challenge of Biological Terrorism, p. 95.Google Scholar
  43. 78.
    Cordesman (2005), The Challenge of Biological Terrorism, p. 96.Google Scholar
  44. 81.
    Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology (2004), Biotechnology Research in an Age of Terrorism, p. 16.Google Scholar
  45. 82.
  46. 83.
    Cf. J.D. Steinbruner, E.D. Harris, N. Galladher and S.M. Okutani (2005), Controlling Dangerous Pathogens (College Park, MD: Center for International and Security Studies at Maryland) http://www.cissm.umd.edu/papers/files/pathogens_project_monograph.pdf, date accessed 11 August 2010.Google Scholar
  47. 84.
    Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, Development, Security, and Cooperation Policy and Global Affairs Division, Board on Global Health, Institute of Medicine and National Research Council of the National Academies (2006), Globalization, Biosecurity, and the Future of the Life Sciences (Washington, D.C.: The National Academies Press), pp. 246–250.Google Scholar
  48. 85.
    N.R.F. Al-Rodhan, L. Nazaruk, M. Finaud and J. Mackby (2008), Global Biosecurity: Towards a New Governance Paradigm (Geneva: Éditions Slatkine), p. 225.Google Scholar
  49. 86.
    A.H. Zakiri, S. Johnston and B. Tobin (2005), ‘The Biodiplomacy Initiative: Informing Equitable and Ethical Decision-Making for Present and Future Generations’, Work in Progress, Vol. 17, No. 2, Summer, http://www.unu.edu/hq/ginfo/wip/wip17-2-summer2005.pdf, date accessed 11 August 2010, 3.Google Scholar
  50. 88.
    T.F. Budinger and M.D. Budinger (2006), Ethics of Emerging Strategic Technologies: Scientific Facts and Moral Challenges (Hoboken, NJ: John Wiley & Sons), p. 342.Google Scholar
  51. 90.
    R.S. Schwartz (2006), ‘The Politics and Promise of Stem-Cell Research’, The New England Journal of Medicine, Vol. 355, No. 12, 21 September, http://content.nejm.org/cgi/content/full/355/12/1189, date accessed 20 August 2010.CrossRefGoogle Scholar
  52. 92.
    G. Harris (2010), ‘U.S. Judge Rules against Obama’s Stem Cel Policy’, The New York Times, 23 August, http://www.nytimes.com/2010/08/24/health/policy/24stem.html?ref=stemcells, date accessed 27 August 2010.
  53. 93.
    S.G. Stolberg and G. Harris (2010), ‘Stem Cell Ruling Will Be Appealed’, The New York Times, 24 August, http://www.nytimes.com/2010/08/25/health/policy/25stem.html?ref=stemcells, date accessed 27 August 2010.
  54. 96.
    A. Bonnicksen (2007), ‘Therapeutic Cloning: Politics and Policy’ in B. Steinbock (ed.) The Oxford Handbook of Bioethics (Oxford: Oxford University Press), p. 444.Google Scholar
  55. 99.
    J. Kuzma (2004), ‘Global Challenges and Biotechnology’, Economic Perspectives, October, 4; K. Pawar, S. P. Pawar, V. A. Patel, H. V. Patel (2010), ‘Promotion of Global Health through Oral Immunotherapy Using Edible Vaccines’, Pharmaceutical Reviews, Vol. 8, No. 1, http://www.pharmainfo.net/reviews/promotion-global-health-through-oral-immunotherapy-using-edible-vaccines, date accessed 10 August 2010.
  56. 100.
    BIO (2008), Guide to Biotechnology 2008, p. 32.Google Scholar
  57. 101.
  58. 102.
  59. 103.
    Ibid., p. 35.Google Scholar
  60. 104.
    Ibid., p. 36.Google Scholar
  61. 105.
    Ibid., p. 37.Google Scholar
  62. 106.
    Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats et al. (2006), Globalization, Biosecurity, and the Future of the Life Sciences, p. 32.Google Scholar
  63. 107.
    Ibid., p. 49.Google Scholar
  64. 108.
  65. 109.
    Ibid., p. 52.Google Scholar
  66. 113.
    M.G. Kortepeter and G.W. Parker (1999), ‘Potential Biological Weapons Threats’, Emerging Infectious Diseases, 1 July, http://www.cdc.gov/ncidod/eid/vol5no4/kortepeter.htm, date accessed 11 August 2010.

Copyright information

© Nayef R.F. Al-Rodhan 2011

Authors and Affiliations

  • Nayef R. F. Al-Rodhan
    • 1
    • 2
  1. 1.St Antony’s CollegeOxford UniversityUK
  2. 2.Geneva Centre for Security PolicyGenevaSwitzerland

Personalised recommendations